Andrés Blanco is an assistant professor of biomedical science at Penn’s School of Veterinary Medicine.
(Image: John Donges)
Promising inhibitor combination for hard-to-treat leukemia subtypes
Researchers from Penn Vet and other institutions have identified a novel inhibitor combination of molecules that induce terminal differentiation for the treatment of human non-APL subtypes of AML.
Melissa Teixeira discusses the final assignment with her Inflationary Times history class.
nocred
Exploring inflation and economics through the lens of history
In Inflationary Times, a history course from Melissa Teixeira, students grappled with big-picture concepts of debt, money, and currency across the globe and through time.
Dad able to look to future after biomarker testing, targeted drug therapy treat his Stage 4 cancer
Chris D’Avella of the Perelman School of Medicine says that are certain targetable mutations in tumors that drive the growth of non-smoking-related lung cancer.
